A multicenter, randomized, double-blind, controlled study on the injection of two kinds of dexamethasone palmitate in the treatment of rheumatoid arthritis
10.3760/cma.j.issn.1007-7480.2012.06.008
- VernacularTitle:两种地塞米松棕榈酸酯注射液治疗类风湿关节炎的多中心随机双盲对照观察
- Author:
Junhua GUO
;
Feng HUANG
;
Jianglin ZHANG
;
Husheng WU
;
Hui SONG
;
Huji XU
;
Yu LIU
;
Jieruo GU
;
Jianlin HUANG
;
Yongfei FANG
;
Ronghua ZHANG
- Publication Type:Journal Article
- Keywords:
Arthritis,rheumatoid;
Dexamethasone;
Randomized controlled trials
- From:
Chinese Journal of Rheumatology
2012;16(6):393-397
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of two forms of preparations of dexamethasone palmitate in the treatment of rheumatoid arthritis (RA).Methods A multicenter,double-blind,randomized,parallel-group clinical trial was carried out according to good clinical practice (GCP).A total of 237cases of RA patients with mild to moderate knee swelling were randomly divided into the treatment group (n=118 ) or the control group (n=119) and were treated with two kinds of dexamethasone palmitate 8 mg injection respectively.The primary efficacy endpoints were the circumference of the knee joint at the upper and the lower edge after the intra-articular injection.The secondary efficacy endpoints were joint tenderness index and patients general assessment.The adveme events were recorded.Analysis of covariance,t test or Wilcoxon test,x2 test or Fisher exact test were used for statistical analysis.Results The upper edges of the treatment group and the control group after treatment were (37.2±3.3) cm and (36.4±3.9) cm respectively,and the lower edges of the two groups were (34.4±2.9) cm and (33.9±3.4) cm respectively.They were all significantly smaller than the edges before treatment [(38.1± 3.3) cm and (37.3±4.0) cm of the upper edges,(35.1±3.0)cm and (34.6±3.6) cm of the lower edges respectively ) (P＜0.O1)].After treatment,the joint tenderness index were improved (P＜0.01).A total ratio of great improvement and improvement of patients general assessment of the two group patients were 67.5％ (79/117) and 74.8％ (86/115) respectively.No statistical significant difference was found in all primary and secondary efficacy endpoints between the two groups (P＞0.05).During the clinical trial,the incidence of adverse events related to the treatment of two groups were 4.2％ and 6.8％,without any significant difference (P＞0.05).Conclusion New preparation of dexamethasone palmitate has the same efficacy and safety as the imported producted in the treatment of RA.The circumference of the knee joints at the upper and the lower edge may be used to assess the effects of intra-articular injections.
